David Berhanu

David Berhanu is a Research Fellow and Clinical Neuroradiologist at the Nuffield Department of Clinical Neuroscience, University of Oxford. His institutional affiliations include:

• Neuroimaging and Neuroinflammation Research groups
• Diagnostic and Advisory Service for Neuromyelitis Optica
• Multiple Sclerosis Clinical Trials Unit

Holding an MD and Postgraduate Diploma, he combines clinical expertise with research in neurological disorders. His work focuses on neuroinflammatory conditions through advanced imaging and clinical analysis.

Dr. Berhanu's research centers on neuroimaging applications in autoimmune disorders, particularly Multiple Sclerosis and Neuromyelitis Optica. He investigates diagnostic techniques like optic nerve sheath ultrasonography, environmental impacts of smoking on disease progression, and patient information-seeking behaviors. His methodology emphasizes systematic reviews and meta-analyses to synthesize clinical evidence.

His 2023 publications reveal a multidisciplinary approach spanning diagnostic innovation, patient-centered outcomes, and rare autoimmune conditions. This work demonstrates strong translational focus—converting clinical observations into evidence-based practices for neuroinflammatory disorders.

As part of Oxford's Multiple Sclerosis Clinical Trials Unit, Dr. Berhanu accesses resources for active neuroimaging studies and clinical trials. While specific grants aren't listed, his role implies funding support for neuroimmunology research. He mentors through research group activities though formal student lists aren't public.

He leads the Neuroimaging and Neuroinflammation Research groups, fostering collaboration between clinicians, imaging specialists, and neuroscientists. This environment enables integrated investigation of neurological disorders using advanced MRI techniques and clinical data analysis.